InvestorsHub Logo
icon url

Meowza

07/17/23 8:21 AM

#412071 RE: dukesking #412068

Why perform quality due diligence once, when you can attempt lower quality DD over and over?

No wonder health care is so expensive.
icon url

johnhancoque

07/17/23 9:21 AM

#412076 RE: dukesking #412068

Then it's purely political. Check see which states lean left or right
icon url

JRoon71

07/17/23 9:22 AM

#412077 RE: dukesking #412068

Everyone should keep in mind that "Blue Cross Blue Shield" is just a licensing affiliation. There are 34 independently owned and operated BC/BS affiliated insurance companies that belong to the "association". And each make their own, independent decisions on coverage.
icon url

roadkilll

07/17/23 9:52 AM

#412079 RE: dukesking #412068

Always up to companies to defend their drugs against patent abuse. Get aggressive now that the Supreme Court looked at Teva being fined $285 million for infringing a GSK use patent. Target generic manufacturers to enforce skinny labels take actions to halt infringement or pull their drug.
CV added protection is the primary patent of use of Vascepa. Not a frivolous use patent created to extend patent protection.